|Type||Public (JSE: MDC)|
Mediclinic International, founded in 1983, is an international private hospital group with operations in South Africa, Namibia, Switzerland and the United Arab Emirates, and listed on the JSE, the South African securities exchange, since 1986. The Group's head office is based in Stellenbosch, South Africa.
Mediclinic Southern Africa, with more than 50 hospitals in South Africa and Namibia, is one of the three largest private hospital groups in the subcontinent. The company is listed on the JSE and has a market-share of approximately 25%. Mediclinic Southern Africa currently operates 6 915 licenced beds and has more than 12 000 full-time employees.
Mediclinic Middle East holds a controlling interest in Emirates Healthcare Holdings based in Dubai, United Arab Emirates. Welcare World comprises seven world class medical centres that offer complete medicare services in the Middle East Region.
Mediclinic Europe operates Hirslanden AG, the leading private hospital group in Switzerland. Hirslanden has 14 clinics, 100 "centres of competence" and specialist institutes as well as a broad range of medical services.
Mediclinic International was founded in 1983 when its current chairman, Dr Edwin Hertzog, was commissioned by the then Rembrandt Group (now Remgro Group) to undertake a feasibility study on how profitable private hospitals could be. Three years later Mediclinic International, running four hospitals with 691 beds in commission and three hospitals with 688 beds under construction, listed on the JSE Limited, the South African stock exchange in 1986.
Today, the group has operations in Southern Africa, Switzerland and the United Arab Emirates: Mediclinic Southern Africa operates 49 hospitals throughout South Africa and three in Namibia with more than 7,000 beds in total; Hirslanden operates 14 private acute care facilities in Switzerland with 1,365 beds; and Emirates Healthcare operates two hospitals with 336 beds and eight clinics in Dubai, United Arab Emirates.
Mediclinic International owns 50.4% of Emirates Healthcare Holdings, with the remaining interest held by the Varkey Group (44.4%) and GE (5.2%).
||This article includes a list of references, related reading or external links, but its sources remain unclear because it lacks inline citations. (April 2014)|